Related Experiment Video
Updated: May 12, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
P2 purinergic signaling and pruritus
Shipan Liu1, Yuanyuan Zhang2, Guilin Li2
1Neuropharmacology Laboratory of Physiology Department, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China; Class 2103, First Clinical Medical College of Nanchang University, Nanchang 330031, China.
Purinergic signaling, involving P2 receptors, plays a key role in skin pruritus (itch). Targeting these P2 receptors offers potential new therapies for various itchy skin conditions.
Area of Science:
- Dermatology
- Neuroscience
- Pharmacology
Background:
- Pruritus, or itch, is a common sensation often leading to scratching.
- Purinergic signaling, mediated by extracellular nucleotides/nucleosides and their receptors, is implicated in itch pathways but not fully understood.
- P2X and P2Y receptors are expressed in skin cells and sensory neurons involved in itch.
Purpose of the Study:
- To review the role of P2 purinergic signaling in the pathogenesis of skin pruritus.
- To explore the potential of P2 receptor antagonism as a therapeutic strategy for pruritus.
Main Methods:
- Review of existing literature on purinergic signaling and pruritus.
- Analysis of studies investigating P2 receptor expression and function in skin and sensory ganglia.
- Examination of the interplay between P2 receptors and other itch mediators.
Main Results:
- P2 purinergic signaling is involved in the pathology of various pruritic skin disorders.
- P2 receptor interactions with histamine, TRP, and MrgprA3 receptors contribute to itch signaling.
- P2 purinergic receptor agonists induce itching behaviors, while antagonists alleviate pruritic symptoms.
Conclusions:
- P2 receptors are integral to the pathogenesis of pruritus.
- Targeting P2 receptors in the skin and sensory ganglia presents promising therapeutic avenues for pruritus relief.
More Related Videos
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Related Concept Videos
Nociception
IP3/DAG Signaling Pathway
GPCR Desensitization
Analgesia and Pain Management
Parasympathetic Signaling
The effects of...
GPCRs Regulate Adenylyl Cylase Activity